Title

A Phase I Trial of Bortezomib in Combination with Everolimus for Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma.

Document Type

Journal Article

Publication Date

3-1-2018

Journal

Leukemia & lymphoma

Volume

59

Issue

3

Inclusive Pages

690-694

DOI

10.1080/10428194.2017.1347932

Keywords

Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Drug Resistance, Neoplasm; Everolimus; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Remission Induction; Salvage Therapy; Survival Rate

Peer Reviewed

1

This document is currently not available here.

Share

COinS